The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali

Boubacar Traore, Younoussou Koné, Safiatou Doumbo, Didier Doumtabé, Abdramane Traoré, Peter D. Crompton, Marko Mircetic, Chiung Yu Huang, Kassoum Kayentao, Alassane Dicko, Issaka Sagara, Ruth D. Ellis, Kazutoyo Miura, Agnes Guindo, Louis H. Miller, Ogobara K. Doumbo, Susan K. Pierce

Research output: Contribution to journalArticle

Abstract

Antibodies play a key role in controlling blood stage malaria infections, and an effective blood stage malaria vaccine will likely require that it induce vaccine-specific memory B cells (MBCs). Our previous studies showed that the addition of the TLR9 agonist CpG to Plasmodium falciparum protein subunit vaccines greatly increased their efficacy in inducing MBCs in nonimmune U.S. volunteers. Here we show that in contrast the same CpG-containing malaria vaccine did not enhance the acquisition of MBCs in semi-immune adults living in Mali. Understanding the molecular basis of this apparent refractoriness to TLR9 agonist will be of significant interest in vaccine design.

Original languageEnglish (US)
Pages (from-to)7299-7303
Number of pages5
JournalVaccine
Volume27
Issue number52
DOIs
StatePublished - Dec 9 2009
Externally publishedYes

Fingerprint

Mali
Plasmodium falciparum
agonists
B-lymphocytes
Malaria Vaccines
B-Lymphocytes
Vaccines
vaccines
Subunit Vaccines
subunit vaccines
blood
Protein Subunits
protein subunits
malaria
Malaria
volunteers
Volunteers
antibodies
Antibodies
Infection

Keywords

  • Malaria
  • Memory B cells
  • Plasmodium falciparum
  • Toll-like receptor 9

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Traore, B., Koné, Y., Doumbo, S., Doumtabé, D., Traoré, A., Crompton, P. D., ... Pierce, S. K. (2009). The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali. Vaccine, 27(52), 7299-7303. https://doi.org/10.1016/j.vaccine.2009.08.023

The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali. / Traore, Boubacar; Koné, Younoussou; Doumbo, Safiatou; Doumtabé, Didier; Traoré, Abdramane; Crompton, Peter D.; Mircetic, Marko; Huang, Chiung Yu; Kayentao, Kassoum; Dicko, Alassane; Sagara, Issaka; Ellis, Ruth D.; Miura, Kazutoyo; Guindo, Agnes; Miller, Louis H.; Doumbo, Ogobara K.; Pierce, Susan K.

In: Vaccine, Vol. 27, No. 52, 09.12.2009, p. 7299-7303.

Research output: Contribution to journalArticle

Traore, B, Koné, Y, Doumbo, S, Doumtabé, D, Traoré, A, Crompton, PD, Mircetic, M, Huang, CY, Kayentao, K, Dicko, A, Sagara, I, Ellis, RD, Miura, K, Guindo, A, Miller, LH, Doumbo, OK & Pierce, SK 2009, 'The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali', Vaccine, vol. 27, no. 52, pp. 7299-7303. https://doi.org/10.1016/j.vaccine.2009.08.023
Traore, Boubacar ; Koné, Younoussou ; Doumbo, Safiatou ; Doumtabé, Didier ; Traoré, Abdramane ; Crompton, Peter D. ; Mircetic, Marko ; Huang, Chiung Yu ; Kayentao, Kassoum ; Dicko, Alassane ; Sagara, Issaka ; Ellis, Ruth D. ; Miura, Kazutoyo ; Guindo, Agnes ; Miller, Louis H. ; Doumbo, Ogobara K. ; Pierce, Susan K. / The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali. In: Vaccine. 2009 ; Vol. 27, No. 52. pp. 7299-7303.
@article{c7791ce1343e4433948bb07503e2f1e2,
title = "The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali",
abstract = "Antibodies play a key role in controlling blood stage malaria infections, and an effective blood stage malaria vaccine will likely require that it induce vaccine-specific memory B cells (MBCs). Our previous studies showed that the addition of the TLR9 agonist CpG to Plasmodium falciparum protein subunit vaccines greatly increased their efficacy in inducing MBCs in nonimmune U.S. volunteers. Here we show that in contrast the same CpG-containing malaria vaccine did not enhance the acquisition of MBCs in semi-immune adults living in Mali. Understanding the molecular basis of this apparent refractoriness to TLR9 agonist will be of significant interest in vaccine design.",
keywords = "Malaria, Memory B cells, Plasmodium falciparum, Toll-like receptor 9",
author = "Boubacar Traore and Younoussou Kon{\'e} and Safiatou Doumbo and Didier Doumtab{\'e} and Abdramane Traor{\'e} and Crompton, {Peter D.} and Marko Mircetic and Huang, {Chiung Yu} and Kassoum Kayentao and Alassane Dicko and Issaka Sagara and Ellis, {Ruth D.} and Kazutoyo Miura and Agnes Guindo and Miller, {Louis H.} and Doumbo, {Ogobara K.} and Pierce, {Susan K.}",
year = "2009",
month = "12",
day = "9",
doi = "10.1016/j.vaccine.2009.08.023",
language = "English (US)",
volume = "27",
pages = "7299--7303",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "52",

}

TY - JOUR

T1 - The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali

AU - Traore, Boubacar

AU - Koné, Younoussou

AU - Doumbo, Safiatou

AU - Doumtabé, Didier

AU - Traoré, Abdramane

AU - Crompton, Peter D.

AU - Mircetic, Marko

AU - Huang, Chiung Yu

AU - Kayentao, Kassoum

AU - Dicko, Alassane

AU - Sagara, Issaka

AU - Ellis, Ruth D.

AU - Miura, Kazutoyo

AU - Guindo, Agnes

AU - Miller, Louis H.

AU - Doumbo, Ogobara K.

AU - Pierce, Susan K.

PY - 2009/12/9

Y1 - 2009/12/9

N2 - Antibodies play a key role in controlling blood stage malaria infections, and an effective blood stage malaria vaccine will likely require that it induce vaccine-specific memory B cells (MBCs). Our previous studies showed that the addition of the TLR9 agonist CpG to Plasmodium falciparum protein subunit vaccines greatly increased their efficacy in inducing MBCs in nonimmune U.S. volunteers. Here we show that in contrast the same CpG-containing malaria vaccine did not enhance the acquisition of MBCs in semi-immune adults living in Mali. Understanding the molecular basis of this apparent refractoriness to TLR9 agonist will be of significant interest in vaccine design.

AB - Antibodies play a key role in controlling blood stage malaria infections, and an effective blood stage malaria vaccine will likely require that it induce vaccine-specific memory B cells (MBCs). Our previous studies showed that the addition of the TLR9 agonist CpG to Plasmodium falciparum protein subunit vaccines greatly increased their efficacy in inducing MBCs in nonimmune U.S. volunteers. Here we show that in contrast the same CpG-containing malaria vaccine did not enhance the acquisition of MBCs in semi-immune adults living in Mali. Understanding the molecular basis of this apparent refractoriness to TLR9 agonist will be of significant interest in vaccine design.

KW - Malaria

KW - Memory B cells

KW - Plasmodium falciparum

KW - Toll-like receptor 9

UR - http://www.scopus.com/inward/record.url?scp=70649098244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70649098244&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2009.08.023

DO - 10.1016/j.vaccine.2009.08.023

M3 - Article

C2 - 19712767

AN - SCOPUS:70649098244

VL - 27

SP - 7299

EP - 7303

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 52

ER -